Novel Strategies in the Development of New Therapies, Drug Substances, and Drug Carriers Volume II

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2023 Mar 29

PMID 36982694

Authors

Andrzej Kutner

Geoffrey Brown

Eniko Kallay

Affiliations

Soon will be listed here.

Abstract

The highly successful previous Volume 1 [...].

Citing Articles

Novel Strategies in the Development of New Therapies, Drug Substances, and Drug Carriers Volume II.

Kutner A, Brown G, Kallay E Int J Mol Sci. 2023; 24(6).

PMID: 36982694 PMC: 10053869. DOI: 10.3390/ijms24065621.

References

Czelen P, Skotnicka A, Szefler B . Designing and Synthesis of New Isatin Derivatives as Potential CDK2 Inhibitors. Int J Mol Sci. 2022; 23(14). PMC: 9316372. DOI: 10.3390/ijms23148046. View

Vaccarin C, Gabbia D, Franceschinis E, De Martin S, Roverso M, Bogialli S . Improved Trimethylangelicin Analogs for Cystic Fibrosis: Design, Synthesis and Preliminary Screening. Int J Mol Sci. 2022; 23(19). PMC: 9570109. DOI: 10.3390/ijms231911528. View

Brown G . Antagonizing RARγ Drives Necroptosis of Cancer Stem Cells. Int J Mol Sci. 2022; 23(9). PMC: 9105400. DOI: 10.3390/ijms23094814. View

Kutner A, Brown G, Kallay E . Novel Strategies in the Development of New Therapies, Drug Substances, and Drug Carriers Volume II. Int J Mol Sci. 2023; 24(6). PMC: 10053869. DOI: 10.3390/ijms24065621. View

Szefler B, Czelen P . Will the Interactions of Some Platinum (II)-Based Drugs with B-Vitamins Reduce Their Therapeutic Effect in Cancer Patients? Comparison of Chemotherapeutic Agents such as Cisplatin, Carboplatin and Oxaliplatin-A Review. Int J Mol Sci. 2023; 24(2). PMC: 9862491. DOI: 10.3390/ijms24021548. View

Mazzanti L, Ha-Duong T . Understanding Passive Membrane Permeation of Peptides: Physical Models and Sampling Methods Compared. Int J Mol Sci. 2023; 24(5). PMC: 10003141. DOI: 10.3390/ijms24055021. View

Gurba-Bryskiewicz L, Dawid U, Smuga D, Maruszak W, Delis M, Szymczak K . Implementation of QbD Approach to the Development of Chromatographic Methods for the Determination of Complete Impurity Profile of Substance on the Preclinical and Clinical Step of Drug Discovery Studies. Int J Mol Sci. 2022; 23(18). PMC: 9505031. DOI: 10.3390/ijms231810720. View

Jurutka P, Di Martino O, Reshi S, Mallick S, Sausedo M, Moen G . An Isochroman Analog of CD3254 and Allyl-, Isochroman-Analogs of NEt-TMN Prove to Be More Potent Retinoid-X-Receptor (RXR) Selective Agonists Than Bexarotene. Int J Mol Sci. 2022; 23(24). PMC: 9782500. DOI: 10.3390/ijms232416213. View

Wegrzynowska-Drzymalska K, Mylkie K, Nowak P, Mlynarczyk D, Chelminiak-Dudkiewicz D, Kaczmarek H . Dialdehyde Starch Nanocrystals as a Novel Cross-Linker for Biomaterials Able to Interact with Human Serum Proteins. Int J Mol Sci. 2022; 23(14). PMC: 9320567. DOI: 10.3390/ijms23147652. View

10.

Stolarczyk E, Strzempek W, Laszcz M, Les A, Menaszek E, Stolarczyk K . Thiogenistein-Antioxidant Chemistry, Antitumor Activity, and Structure Elucidation of New Oxidation Products. Int J Mol Sci. 2022; 23(14). PMC: 9315507. DOI: 10.3390/ijms23147816. View

11.

Gleba J, Klopotowska D, Banach J, Mielko K, Turlej E, Maciejewska M . Micro-RNAs in Response to Active Forms of Vitamin D in Human Leukemia and Lymphoma Cells. Int J Mol Sci. 2022; 23(9). PMC: 9104187. DOI: 10.3390/ijms23095019. View

12.

Witkowski J, Polak S, Pawelec D, Rogulski Z . In Vitro/In Vivo Translation of Synergistic Combination of MDM2 and MEK Inhibitors in Melanoma Using PBPK/PD Modelling: Part III. Int J Mol Sci. 2023; 24(3). PMC: 9917191. DOI: 10.3390/ijms24032239. View

13.

Wu Y, Pegan S, Crich D, Lou L, Mullininx L, Starling E . Identifying Drug Candidates for COVID-19 with Large-Scale Drug Screening. Int J Mol Sci. 2023; 24(5). PMC: 10002104. DOI: 10.3390/ijms24054397. View

14.

Zolek T, Yasuda K, Brown G, Sakaki T, Kutner A . In Silico Prediction of the Metabolic Resistance of Vitamin D Analogs against CYP3A4 Metabolizing Enzyme. Int J Mol Sci. 2022; 23(14). PMC: 9322940. DOI: 10.3390/ijms23147845. View

15.

Thiruchenthooran V, Switalska M, Bonilla L, Espina M, Garcia M, Wietrzyk J . Novel Strategies against Cancer: Dexibuprofen-Loaded Nanostructured Lipid Carriers. Int J Mol Sci. 2022; 23(19). PMC: 9570096. DOI: 10.3390/ijms231911310. View

16.

Pawlicka M, Zmorzynski S, Popek-Marciniec S, Filip A . The Effects of Genistein at Different Concentrations on Breast Cancer Cells and Dermal Fibroblasts. Int J Mol Sci. 2022; 23(20). PMC: 9604460. DOI: 10.3390/ijms232012360. View

17.

Braga D, Casali L, Grepioni F . The Relevance of Crystal Forms in the Pharmaceutical Field: Sword of Damocles or Innovation Tools?. Int J Mol Sci. 2022; 23(16). PMC: 9408954. DOI: 10.3390/ijms23169013. View

18.

Witkowska A, Giebultowicz J, Dabrowska M, Stolarczyk E . Development of a Sensitive Screening Method for Simultaneous Determination of Nine Genotoxic Nitrosamines in Active Pharmaceutical Ingredients by GC-MS. Int J Mol Sci. 2022; 23(20). PMC: 9603764. DOI: 10.3390/ijms232012125. View

19.

Szefler B, Czelen P, Wojtkowiak K, Jezierska A . Affinities to Oxaliplatin: Vitamins from B Group vs. Nucleobases. Int J Mol Sci. 2022; 23(18). PMC: 9503415. DOI: 10.3390/ijms231810567. View

20.

Zyzynska-Granica B, Mollica A, Stefanucci A, Granica S, Kleczkowska P . Comparative Study of Chemical Stability of a PK20 Opioid-Neurotensin Hybrid Peptide and Its Analogue [Ile]PK20-The Effect of Isomerism of a Single Amino Acid. Int J Mol Sci. 2022; 23(18). PMC: 9500858. DOI: 10.3390/ijms231810839. View